Therapeutic Potential of Cystatin 9 Treatment to Fight Bacterial Pneumonia

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

Bernard Arulanandam

Funded by

Univ of TX Medical Branch Galveston 723

Research Start Date

11/01/2015

Status

Active

Basic Research

Collaborative Project

Basic Research

Drug Discovery

Clinical Care

Infectious Disease

Bioscience Research Panel